(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XERECEPT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

XERECEPT

ST13

US500000079439594

Class

5

Filing

79439594

Registration

8268708

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

06/25/2026

Trademark type

Word

Nice classes

5

Filing date

10/14/2025

Registration date

05/26/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/26/2026

Last transaction

06/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

O'BRIEN, JENNIFER LYNN

Law office

N30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Curatis AG

Representatives

Mackenzie M. Lawrence Hovey Williams LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary productsin particular medicines for cancer treatment and medicines for treatment of edema resulting from cancer.

Publications

History of USPTO decisions and trademark events.

19 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/25/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/26/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/26/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/07/2026

PUBO

PUBLISHED FOR OPPOSITION

04/07/2026

GPNX

NOTIFICATION PROCESSED BY IB

04/02/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/01/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/18/2026

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/18/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/10/2026

DOCK

ASSIGNED TO EXAMINER

03/03/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/29/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/09/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/09/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/09/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/09/2026

MAFR

APPLICATION FILING RECEIPT MAILED

12/29/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/29/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/18/2025

Continuous trademark protection

Get notified about every new filing that threatens XERECEPT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.